Activation of intracellular signaling systems by high-density lipoproteins

被引:12
作者
Toth, Peter P. [1 ,2 ]
机构
[1] Sterling Rock Falls Clin, Sterling, IL 61081 USA
[2] Univ Illinois, Sch Med, Peoria, IL USA
关键词
High-density lipoproteins; G-protein coupled receptor; Nitric oxide; Protein kinase; Proteosome; Scavenger receptor BI; Sphingosine phosphate; NITRIC-OXIDE SYNTHASE; SPHINGOSINE; 1-PHOSPHATE; HDL; CHOLESTEROL; RECEPTOR; INHIBITION; STABILIZATION; PATHOGENESIS; MECHANISMS; EXPRESSION;
D O I
10.1016/j.jacl.2010.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The proteosome of high-density lipoprotein particles is quite complex and consists of up to 75 different proteins and enzymes. The specific protein cargo of HDL particles regulates their functionality. In addition to their documented capacity to engage in reverse cholesterol transport, reduce oxidized lipid, and function as apoprotein donors, HDL particles can activate a variety of signaling systems in endothelial cells, smooth muscle cells, and platelets. The HDLs can deliver sphingolipids to the surface of these cell types and activate sphingosine phosphate receptors. Sphingosine phosphate receptors are coupled to numerous different intracellular signaling cascades exerting roles in vasodilatation, inflammation, cell migration and apoptosis, inhibition of platelet activation, and endothelial adhesion molecule expression, among other functions. The ability of HDL to influence such a diverse array of cellular functions lends biological plausibility to the substantial epidemiological and clinical evidence suggesting that the HDLs are unique among lipoproteins in that they are vasculoprotective and antiatherogenic. (C) 2010 National Lipid Association. All rights reserved.
引用
收藏
页码:376 / 381
页数:6
相关论文
共 37 条
[1]   Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor [J].
Ahmed, Z ;
Ravandi, A ;
Maguire, GF ;
Emili, A ;
Draganov, D ;
La Du, BN ;
Kuksis, A ;
Connelly, PW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24473-24481
[2]   Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment [J].
Ansell, BJ ;
Navab, M ;
Hama, S ;
Kamranpour, N ;
Fonarow, G ;
Hough, G ;
Rahmani, S ;
Mottahedeh, R ;
Dave, R ;
Reddy, ST ;
Fogelman, AM .
CIRCULATION, 2003, 108 (22) :2751-2756
[3]   HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects [J].
Argraves, Kelley M. ;
Argraves, W. Scott .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2325-2333
[4]   Atheroprotective effects of high-density lipoproteins [J].
Assmann, G ;
Nofer, JR .
ANNUAL REVIEW OF MEDICINE, 2003, 54 :321-341
[5]   Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].
Aviram, M ;
Hardak, E ;
Vaya, J ;
Mahmood, S ;
Milo, S ;
Hoffman, A ;
Billicke, S ;
Draganov, D ;
Rosenblat, M .
CIRCULATION, 2000, 101 (21) :2510-2517
[6]   THROMBOXANE-A2 (TXA2) FORMATION BY WASHED HUMAN-PLATELETS UNDER THE INFLUENCE OF LOW AND HIGH-DENSITY-LIPOPROTEINS FROM HEALTHY DONORS [J].
BEITZ, J ;
MEST, HJ .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 23 (2-3) :303-309
[7]   Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease [J].
Brewer, HB ;
Remaley, AT ;
Neufeld, EB ;
Basso, F ;
Joyce, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :1755-1760
[8]   Modulation of smooth muscle cell migration by members of the low-density lipoprotein receptor family [J].
Bujo, H ;
Saito, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (06) :1246-1252
[9]   Endothelial protection by high-density lipoproteins - From bench to bedside [J].
Calabresi, L ;
Gomaraschi, M ;
Franceschini, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (10) :1724-1731
[10]   Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins [J].
Calabresi, L ;
Franceschini, G ;
Sirtori, CR ;
DePalma, A ;
Saresella, M ;
Ferrante, P ;
Taramelli, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (01) :61-65